Esaurito ma molto ricercato!
Maggiori informazioni sul libro
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Acquisto del libro
The Pharmagellan Guide to Biotech Forecasting and Valuation, Andrew Matthews, Frank S. David, Seth Robey
- Lingua
- Pubblicato
- 2017
- product-detail.submit-box.info.binding
- (In brossura)
Ti avviseremo via email non appena lo rintracceremo.
Metodi di pagamento
Qui potrebbe esserci la tua recensione.
- Titolo
- The Pharmagellan Guide to Biotech Forecasting and Valuation
- Lingua
- Inglese
- Autori
- Andrew Matthews, Frank S. David, Seth Robey
- Editore
- Pharmagellan
- Pubblicato
- 2017
- Formato
- In brossura
- Pagine
- 138
- ISBN10
- 099840750X
- ISBN13
- 9780998407500
- Serie
- Valutazione
- 4,3 su 5
- Descrizione
- If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.